Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AZD 8797 is a chemokine (C-X3-C motif) receptor 1 (CX3CR1) antagonist (Ki = 3.9 nM). It is selective for CX3CR1 over CX3CR2 (Ki = 2,800 nM).1 AZD 8797 (0.1-10 µM) inhibits [35S]GTPγS accumulation induced by chemokine (C-X3-C) ligand 1 (CX3CL1) in CHO cell membranes expressing human CX3CR1.2 It inhibits adhesion of RBMI-8226 cells to CX3CL1 (IC50 = 5.8 nM). AZD 8797 (39 and 78 µmol/kg per day) reduces spinal cord inflammation and demyelination, as well as the incidence of disease relapse, in a rat model of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (EAE).3
WARNING This product is not for human or veterinary use.
1. .
2. .
3. .